metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Clonal T lymphocytosis resolution after adalimumab discontinuation
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Clonal T lymphocytosis resolution after adalimumab discontinuation
Resolución de una linfocitosis T clonal tras la suspensión de adalimumab
Rosalía Alonso Trilloa, Jose Antonio García Velab,
Corresponding author
a Hospital Universitario de Getafe, Spain
b Hospital Universitario Puerta de Hierro Majadahonda, Spain
Read
13
Times
was read the article
0
Total PDF
13
Total HTML
Share statistics
 array:23 [
  "pii" => "S0025775323006772"
  "issn" => "00257753"
  "doi" => "10.1016/j.medcli.2023.11.006"
  "estado" => "S300"
  "fechaPublicacion" => "2024-04-26"
  "aid" => "6481"
  "copyright" => "Elsevier España, S.L.U.. All rights reserved"
  "copyrightAnyo" => "2023"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Med Clin. 2024;162:402-3"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0025775323007121"
    "issn" => "00257753"
    "doi" => "10.1016/j.medcli.2023.11.012"
    "estado" => "S300"
    "fechaPublicacion" => "2024-04-26"
    "aid" => "6497"
    "copyright" => "Elsevier España, S.L.U."
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Med Clin. 2024;162:403-4"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>"
      "titulo" => "Escabiosis resistente a permetrina"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "403"
          "paginaFinal" => "404"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Permethrin-resistant scabies"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mar Luque-Luna, Llu&#237;s Corbella-Bagot, Priscila Giavedoni"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Mar"
              "apellidos" => "Luque-Luna"
            ]
            1 => array:2 [
              "nombre" => "Llu&#237;s"
              "apellidos" => "Corbella-Bagot"
            ]
            2 => array:2 [
              "nombre" => "Priscila"
              "apellidos" => "Giavedoni"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2387020624001177"
        "doi" => "10.1016/j.medcle.2024.04.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624001177?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323007121?idApp=UINPBA00004N"
    "url" => "/00257753/0000016200000008/v2_202404281220/S0025775323007121/v2_202404281220/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0025775323006760"
    "issn" => "00257753"
    "doi" => "10.1016/j.medcli.2023.11.005"
    "estado" => "S300"
    "fechaPublicacion" => "2024-04-26"
    "aid" => "6480"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Med Clin. 2024;162:401-2"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>"
      "titulo" => "Lesi&#243;n pulmonar por onda expansiva en buceo recreativo"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "401"
          "paginaFinal" => "402"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Blast lung injury in recreational diving"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1111
              "Ancho" => 1138
              "Tamanyo" => 155918
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">TC que muestra hemorragia intraalveolar en el seno de laceraciones pulmonares &#40;se&#241;aladas con asterisco&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Santiago G&#243;mez Estanga, Elena Cuenca Fito, Rita Galeiras"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Santiago"
              "apellidos" => "G&#243;mez Estanga"
            ]
            1 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Cuenca Fito"
            ]
            2 => array:2 [
              "nombre" => "Rita"
              "apellidos" => "Galeiras"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2387020624001165"
        "doi" => "10.1016/j.medcle.2023.11.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020624001165?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323006760?idApp=UINPBA00004N"
    "url" => "/00257753/0000016200000008/v2_202404281220/S0025775323006760/v2_202404281220/es/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
    "titulo" => "Clonal T lymphocytosis resolution after adalimumab discontinuation"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Dear Editor</span>&#44;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "402"
        "paginaFinal" => "403"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Rosal&#237;a Alonso Trillo, Jose Antonio Garc&#237;a Vela"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Rosal&#237;a"
            "apellidos" => "Alonso Trillo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Jose Antonio"
            "apellidos" => "Garc&#237;a Vela"
            "email" => array:1 [
              0 => "garciavela.joseantonio@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Hospital Universitario de Getafe&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Hospital Universitario Puerta de Hierro Majadahonda&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Resoluci&#243;n de una linfocitosis T clonal tras la suspensi&#243;n de adalimumab"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hepatosplenic T-cell lymphoma &#40;HSTCL&#41; is a rare&#44; aggressive T-cell lymphoma&#44; constituting 1&#46;5&#8211;2&#37; of peripheral T-cell lymphomas&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Outcomes generally are poor due to a rapidly progressive course and limited treatment response&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The association between inflammatory bowel disease &#40;IBD&#41;&#44; biological treatment&#44; and increased hepatosplenic T-cell lymphoma incidence remains a topic of debate&#46; In healthy adults&#44; &#947;&#948;-T cells represent less than 5&#37; of circulating lymphocytes&#46; Nevertheless&#44; notable changes in &#947;&#948;-T cells have been observed in the IBD population following anti-TNF&#945; treatment &#40;ATA&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> This observation suggests that a patient subgroup with increased &#947;&#948;-T cells may have a lower threshold for clonal expansion when treated with anti-TNF-&#945; agents&#46; Supporting this notion&#44; we presented the first case report of a patient experiencing clonal &#947;&#948;-T lymphocytosis during adalimumab treatment&#44; showing the absence of T-cell receptor &#40;TCR&#41; clonality post-treatment discontinuation&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">A 48-year-old man with ileocolic Crohn&#39;s disease &#40;Montreal classification A2 L3 B1&#41; and associated spondylarthritis was referred to the Hematology Department for lymphocytosis evaluation&#46; He had a previous history of steroid-dependent disease&#44; necessitating adalimumab treatment as a steroid-sparing agent from February 2017&#46; The maintenance dosage was administered until October 2022&#44; when a new onset of intestinal symptoms required a dose intensification&#46; This led to the emergence of a lymphocytosis&#44; with a total count of 5&#46;88<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">3</span> lymphocytes&#47;&#956;l in peripheral blood &#40;PB&#41;&#46; Flow cytometry analysis revealed 11&#37; of circulating reactive &#947;&#948;-T cells &#40;CD5&#43;&#44; CD38&#43;&#43;&#44; CD56w&#44; CD2&#44; CD7w&#44; CD28&#8722;&#44; CD45RA&#43;&#44; CD57&#43;&#44; granzyme B&#43;&#44; and perforin&#43;&#41; and PCR-based detection of rearranged TCR confirmed the presence of monoclonal TCR&#46; Despite the presence of clonality&#44; the phenotypic profile found did not match with HSCTL immunophenotype mainly due to CD5&#44; CD57 positivity&#44; and the presence of cytotoxic markers &#40;granzyme B and perforin&#41;&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">A CT scan was performed to rule out lymphadenopathies or other organomegalies&#44; revealing no significant radiological findings&#46; However&#44; based on the evidence that clonal lymphocytosis may precede HSCTL development&#44; it was suggested to discontinue adalimumab&#46; Ustekinumab was initiated in November 2022 with excellent tolerance&#46; Three months after discontinuation&#44; total lymphocyte counts normalized&#44; circulating reactive &#947;&#948;-T cells decreased to 6&#46;5&#37; of total lymphocytes&#44; and molecular studies corroborated a polyclonal TCR rearrangement&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">First described in 2002&#44; the association between lymphoma and ATA monotherapy has raised concerns&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> The etiopathogenic mechanisms behind the development of HSCTL in these patients remain poorly understood&#46; This is due to the absence of well-designed studies&#44; long-term follow-up&#44; and the use of concurrent treatments&#44; all of which may bias conclusions&#46; While some studies have not shown an increased rate of HSTCL in patients with IBD receiving anti-TNF&#44; others suggest an elevated risk&#44; particularly in young male patients&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> The latest update from the FDA Adverse Events Reporting System &#40;FAERS&#41; included a total of 62 cases of HSTCL among patients with IBD exposed to biological therapy&#44; with all cases reporting previous exposure to anti-TNF-&#945; agents&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Recently&#44; Kelsen et al&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> hypothesized that a multistep process resulting in clonal &#947;&#948;-T cell expansion may precede neoplastic transformation to HSCTL&#46; Their study investigated &#947;&#948;-T cell behavior in 46 patients with Crohn&#39;s disease &#40;CD&#41;&#58; 20 were treated with infliximab and 26 with adalimumab&#46; A group of 16 healthy individuals was used as a control&#46; The analysis revealed that&#44; in the CD group&#44; 25&#37; of patients had increased baseline &#947;&#948;-T levels &#40;range 5&#8211;15&#37;&#41;&#44; whereas no similar cases were identified in the control group&#46; Furthermore&#44; in this subgroup with an increased proportion of &#947;&#948;-T cells&#44; the initiation of anti-TNF-&#945; treatment led to a significant in vivo expansion of these lymphocytes&#46; Additional in vitro analysis of anti-TNF-&#945; agents ruled out the presence of indirect effects mediated by inflammatory factors or the redistribution of the intestinal lymphocyte pool&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Here&#44; we describe the first case report that shows polyclonal TCR after discontinuing adalimumab&#46; The clone&#39;s disappearance&#44; along with the normalization of total lymphocyte counts and the reduction in circulating &#947;&#948;-T cells after changing the CD treatment&#44; bolsters the hypothesis that the drug might play an etiological role in T cell clone expansion&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Although the benefits of long-term biological therapy are clear&#44; identifying high-risk patients for lymphoma development is crucial for minimizing risks&#46; Monitoring T cell clone expansion&#44; especially in young male patients&#44; before and after using anti-TNF-&#945; agents could assist in selecting the most suitable therapy&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Ethical considerations</span><p id="par0045" class="elsevierStylePara elsevierViewall">The patient had provided informed consent for publication of the case&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Funding</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors have no support or funding to report&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflict of interest</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors declare that they have no competing interests&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:5 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Ethical considerations"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Funding"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflict of interest"
        ]
        3 => array:2 [
          "identificador" => "xack741337"
          "titulo" => "Acknowledgments"
        ]
        4 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incidence and outcomes of rare T cell lymphomas from the T Cell Project&#58; hepatosplenic&#44; enteropathy associated and peripheral gamma delta T cell lymphomas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46;M&#46; Foss"
                            1 => "S&#46;M&#46; Horwitz"
                            2 => "M&#46; Civallero"
                            3 => "M&#46; Bellei"
                            4 => "L&#46; Marcheselli"
                            5 => "W&#46;S&#46; Kim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/ajh.25674"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Hematol"
                        "fecha" => "2020"
                        "volumen" => "95"
                        "paginaInicial" => "151"
                        "paginaFinal" => "155"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31709579"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Infliximab induces clonal expansion of &#947;&#948;-T cells in Crohn&#39;s disease&#58; a predictor of lymphoma risk&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Kelsen"
                            1 => "A&#46; Dige"
                            2 => "H&#46; Schwindt"
                            3 => "F&#46; D&#8217;Amore"
                            4 => "F&#46;S&#46; Pedersen"
                            5 => "J&#46; Agnholt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0017890"
                      "Revista" => array:3 [
                        "tituloSerie" => "PLoS One"
                        "fecha" => "2011"
                        "volumen" => "6"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tumor necrosis factor antagonist therapy and lymphoma development&#58; twenty-six cases reported to the Food and Drug Administration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;L&#46; Brown"
                            1 => "M&#46;H&#46; Greene"
                            2 => "S&#46;K&#46; Gershon"
                            3 => "E&#46;T&#46; Edwards"
                            4 => "M&#46;M&#46; Braun"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.10679"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2002"
                        "volumen" => "46"
                        "paginaInicial" => "3151"
                        "paginaFinal" => "3158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12483718"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Maintenance infliximab for Crohn&#39;s disease&#58; the ACCENT I randomised trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;B&#46; Hanauer"
                            1 => "B&#46;G&#46; Feagan"
                            2 => "G&#46;R&#46; Lichtenstein"
                            3 => "L&#46;F&#46; Mayer"
                            4 => "S&#46; Schreiber"
                            5 => "J&#46;F&#46; Colombel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(02)08512-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2002"
                        "volumen" => "359"
                        "paginaInicial" => "1541"
                        "paginaFinal" => "1549"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12047962"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic review&#58; hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease&#44; including data from the Food and Drug Administration Adverse Event Reporting System"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "E&#46;D&#46; Shah"
                            1 => "E&#46;S&#46; Coburn"
                            2 => "A&#46; Nayyar"
                            3 => "K&#46;J&#46; Lee"
                            4 => "J&#46;L&#46; Koliani-Pace"
                            5 => "C&#46;A&#46; Siegel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/apt.15637"
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2020"
                        "volumen" => "51"
                        "paginaInicial" => "527"
                        "paginaFinal" => "533"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31990422"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack741337"
        "titulo" => "Acknowledgments"
        "texto" => "<p id="par0060" class="elsevierStylePara elsevierViewall">The authors gratefully acknowledge the contribution of the Gastroenterology Department and the Flow Cytometry Laboratory of Hospital de Getafe&#46; We also thank the subject for his participation and for his informed written consent&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/00257753/0000016200000008/v2_202404281220/S0025775323006772/v2_202404281220/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66430"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas al Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00257753/0000016200000008/v2_202404281220/S0025775323006772/v2_202404281220/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775323006772?idApp=UINPBA00004N"
]
Article information
ISSN: 00257753
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 3 0 3
2024 April 4 0 4
2024 January 1 0 1
2023 December 5 0 5

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos